Does Nevada Medicaid
Cover Tagrisso?
Tagrisso (Osimertinib) coverage, costs, and how to get it in Nevada.
Coverage Status
Tagrisso coverage details for Nevada residents.
Cancer medications are covered but require prior authorization to confirm diagnosis and treatment protocol.
How to Get Tagrisso Covered
Steps to get Tagrisso covered by your insurance in Nevada.
Talk to your doctor
Ask your doctor to prescribe Tagrisso and confirm it's appropriate for your condition.
Submit prior authorization
Your doctor's office will submit a prior authorization to Nevada Medicaid. This typically takes 3-5 business days.
Check patient assistance
If coverage is denied, check AstraZeneca's patient assistance program for free or reduced-cost options.
Appeal if needed
You can appeal a coverage denial through Nevada Medicaid. Your doctor can provide supporting documentation.
Need help affording Tagrisso?
Answer 9 questions. See every program you're eligible for. Free.
Tagrisso Side Effects
Common and serious side effects to discuss with your doctor.
⚡ Common Side Effects
- Diarrheacommon
- Rashcommon
- Dry skincommon
- Nail problemscommon
⚠️ Serious Side Effects
- Heart problems (QTc prolongation)uncommon
- Interstitial lung diseaserare
Seek immediate medical attention if you experience any serious side effects.
Frequently Asked Questions
Does Nevada Medicaid cover Tagrisso?
Nevada Medicaid covered (prior auth) Tagrisso. Prior authorization is required. Cancer medications are covered but require prior authorization to confirm diagnosis and treatment protocol.
How much does Tagrisso cost in Nevada?
Without insurance, Tagrisso costs approximately $16,500/month. With Nevada Medicaid, your copay may be $0-$0.
How do I get Tagrisso covered in Nevada?
Contact your Nevada Medicaid office or insurance provider to check coverage. Your doctor will need to submit a prior authorization request.
Get Your Free Benefits Report
Enter your email to receive a personalized report of every benefit program you may qualify for.
No spam. Unsubscribe anytime.